Patents by Inventor Matthew Beaudet

Matthew Beaudet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230384227
    Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Application
    Filed: March 15, 2023
    Publication date: November 30, 2023
    Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
  • Patent number: 11635383
    Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: April 25, 2023
    Inventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
  • Publication number: 20220042915
    Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Application
    Filed: March 24, 2021
    Publication date: February 10, 2022
    Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
  • Patent number: 10962480
    Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: March 30, 2021
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
  • Publication number: 20200292456
    Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Application
    Filed: January 7, 2020
    Publication date: September 17, 2020
    Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
  • Patent number: 10533946
    Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: January 14, 2020
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
  • Publication number: 20180335386
    Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Application
    Filed: March 15, 2018
    Publication date: November 22, 2018
    Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
  • Patent number: 9964490
    Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: May 8, 2018
    Assignee: Life Technologies Corporation
    Inventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
  • Publication number: 20160003743
    Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Application
    Filed: September 11, 2015
    Publication date: January 7, 2016
    Inventors: Matthew Beaudet, Jill HENDRICKSON, David HAGEN, Rich MEYER
  • Publication number: 20150247799
    Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.
    Type: Application
    Filed: March 2, 2015
    Publication date: September 3, 2015
    Inventors: Matthew BEAUDET, William COX, Stephen YUE
  • Patent number: 8969004
    Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: March 3, 2015
    Assignee: Life Technologies Corporation
    Inventors: Matthew Beaudet, William Gregory Cox, Stephen Yue
  • Publication number: 20140076726
    Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.
    Type: Application
    Filed: May 15, 2013
    Publication date: March 20, 2014
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Matthew BEAUDET, William Gregory Cox, Stephen Yue
  • Publication number: 20140011191
    Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.
    Type: Application
    Filed: September 4, 2013
    Publication date: January 9, 2014
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
  • Patent number: 8562802
    Abstract: Cassette electrophoresis systems that allow viewing of molecules during the electrophoresis run are disclosed. Cassette electrophoresis bases that reversibly engage light sources, such as light source bases are disclosed. Also disclosed are visible light transillumination systems for viewing a pattern of fluorescence emitted by fluorophores comprising a cassette housing fluorophore-containing material and a base unit to support the cassette. In some aspects the base unit that includes a power supply also houses a light source having output in the visible wavelength region and a filter placed between the light source and the fluorophores. The system is constructed and arranged such that patterns of fluorescence emitted by the fluorophores are viewable. Also described are charging devices for providing charge to gel electrophoresis systems, portable gel electrophoresis systems and methods of use thereof.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: October 22, 2013
    Assignee: Life Technologies Corporation
    Inventors: Matthew Beaudet, Ilana Margalit, Ronen Benarieh, Andres Wainstein, Gustavo Turkieltaub
  • Patent number: 7977057
    Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: July 12, 2011
    Assignee: Life Technologies Corporation
    Inventors: Matthew Beaudet, Gregory Cox, Stephen Yue
  • Publication number: 20050239096
    Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.
    Type: Application
    Filed: September 30, 2004
    Publication date: October 27, 2005
    Inventors: Matthew Beaudet, W. Cox, Stephen Yue